thehosksaidthehosksaid.com
LIVE INDEX
Library/Stem Cell Freedom Act

Stem Cell Freedom Act

Mar 7, 2026· 14:38· 2.7K views·indexed 3mo ago
THIS VIDEO
Key takeawaysAI summary · 10 points
Charles Hoskinson announced the passage of the Stem Cell Freedom Act (SF 48) in Wyoming, which aims to enhance accessibility to stem cell therapies.
The bill was co-sponsored by Senator Barlow, Senator Briede, Senator Hutchins, and Representatives Clausen and Haroldson.
The Stem Cell Freedom Act allows physicians to recommend and perform stem cell therapy, permits health insurers to cover such therapies, and protects physicians from license actions related to stem cell therapy.
The legislation passed unanimously in both the Wyoming House (59-0) and Senate (31-0), showcasing rare bipartisan support.
The act establishes a framework for administering autologous stem cells and requires compliance with safety standards, particularly for those who have passed phase one of clinical trials.
Hoskinson emphasized the importance of bringing offshore stem cell treatments back to the U.S. and ensuring they are conducted by qualified physicians.
The law aims to revolutionize healthcare in Wyoming, potentially curing chronic ailments and reducing the need for long-term management of diseases.
Hoskinson's clinic, Hoskinson Health, is expanding and building a CGMP lab to facilitate stem cell research and treatments.
The initiative is expected to attract significant funding and expertise to the University of Wyoming, positioning it as a leading center for stem cell clinical trials.
Hoskinson expressed pride in Wyoming's leadership and foresight, noting the potential for the state to lead the nation in regenerative medicine.
Generated from the transcript — jump to any point to verify.